These success, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 guidance the idea of focusing on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-simila